nup132 Antibody

What is NUP132 and what is its role in the nuclear pore complex?

NUP132 (and its ortholog NUP133 in humans) is a crucial component of the nuclear pore complex (NPC). It plays vital roles in both structural organization of the NPC and in RNA transport, particularly poly(A)+ RNA export from the nucleus to the cytoplasm . When NUP132/NUP133 is disrupted or mutated, cells display significant abnormalities including clustering of nuclear pore complexes at specific sites on the nuclear envelope . NUP133 is also involved in nephrogenesis according to some research .

The functional importance of this nucleoporin can be observed in temperature-sensitive mutants, where disruption leads to growth inhibition at restrictive temperatures (37°C) while allowing slower growth at permissive temperatures . This temperature-dependent phenotype makes NUP132/NUP133 an excellent model for studying nuclear transport mechanisms.

How does NUP132 antibody detection compare to other nucleoporin visualization methods?

Researchers have multiple options for visualizing NUP132 and other nucleoporins, each with distinct advantages:

This comparison is particularly relevant for nucleoporins like NUP132 that may be partially located in dense, phase-separated regions of the nuclear pore complex.

What sample preparation protocols optimize NUP132 antibody staining in immunofluorescence?

For optimal NUP132 antibody staining in immunofluorescence applications:

• Fixation method selection: Use 4% paraformaldehyde for 15-20 minutes at room temperature to preserve nuclear membrane structure and nucleoporin localization.

• Permeabilization considerations: Nucleoporins like NUP132 reside in dense protein complexes; therefore:

  • Use 0.2% Triton X-100 for standard permeabilization

  • For phase-separated regions containing nucleoporins, consider stronger permeabilization with 0.5% Triton X-100 or brief methanol treatment

• Blocking protocol: Use 3-5% BSA in PBS with 0.1% Tween-20 for 1 hour at room temperature.

• Antibody dilution optimization: Begin with manufacturer-recommended dilutions (approximately 1-5 μg/ml for commercial antibodies) , then optimize for your specific application.

• Extended incubation periods: Consider overnight primary antibody incubation at 4°C to improve signal in complex nuclear structures.

If traditional antibody detection produces poor results, research indicates that alternative approaches such as TurboID fusion proteins with streptavidin detection may provide superior results for nucleoporins in phase-separated regions .

How can researchers distinguish between individual NUP132 protein recruitment and entire NPC clustering?

Distinguishing between individual NUP132 protein recruitment and full NPC clustering requires quantitative analysis approaches:

• Intensity distribution analysis:

  • Measure Nup-GFP intensities across the nuclear envelope

  • Generate kernel-smoothed density distributions of fluorescence intensity

  • Compare individual data points between experimental conditions

• Multi-color co-localization analysis:

  • Simultaneously visualize NUP132 alongside other NPC components using spectrally distinct fluorophores

  • Calculate Pearson's correlation coefficients between NUP132 and other nucleoporins

  • High correlation coefficients suggest movement of entire NPCs rather than individual proteins

• Electron microscopy validation:

  • Use immunogold labeling with anti-NUP132 antibodies

  • Analyze spatial distribution at ultrastructural level to confirm clustering

Research indicates that NUP132/NUP133-deficient cells display distinctive clustering of nuclear pore complexes at specific sites on the nuclear envelope, suggesting a role in proper NPC distribution rather than just individual protein mislocalization .

What are the implications of NUP132 mutations or depletion on mRNA export and cell viability?

NUP132/NUP133 mutations or depletion lead to multiple cellular phenotypes with significant research implications:

• mRNA export defects:

  • Temperature-sensitive mutants show nuclear accumulation of poly(A)+ RNA

  • These defects occur independently of nuclear protein import defects

  • The amino-terminal domain of NUP133 is specifically required for mRNA export but not for preventing NPC clustering

• Growth and viability effects:

  • Complete disruption of NUP133 is not lethal but causes severe growth defects

  • Cells grow slowly at permissive temperatures but cease growth at 37°C

  • This temperature-sensitive phenotype provides an excellent experimental system for controlled studies

• NPC clustering phenotype:

  • Extensive clustering of nuclear pore complexes occurs at a few sites on the nuclear envelope

  • This clustering can be uncoupled from mRNA export defects under certain conditions

  • An amino-terminally truncated NUP133 allows normal poly(A)+ RNA export but does not complement the clustering phenotype

This multifaceted phenotype makes NUP132/NUP133 an excellent target for studying the relationship between nuclear pore complex organization and function.

How can researchers troubleshoot inconsistent results when using NUP132 antibodies?

When facing inconsistent results with NUP132 antibodies, consider these methodological approaches:

• Epitope accessibility issues:

  • Nucleoporins like NUP132 may reside in phase-separated regions that resist antibody penetration

  • Solution: Try alternative detection methods such as TurboID fusion proteins with streptavidin visualization

  • Compare N-terminal vs. C-terminal tagging, as accessibility varies based on tag position

• Validation through multiple detection methods:

  • Immunofluorescence versus Western blotting discrepancies may indicate context-dependent epitope masking

  • Solution: Use orthogonal detection methods (fluorescent protein tags, proximity labeling)

• Cell type and fixation dependencies:

  • Nuclear pore complex organization varies between cell types and physiological states

  • Solution: Standardize cell cycle phase (e.g., mid-G2) for consistent measurements

  • Compare fixation protocols to identify optimal preservation methods

Research shows that certain NPC regions are consistently inaccessible to antibodies despite protein presence, requiring specialized detection approaches beyond traditional immunofluorescence .

What methods exist for quantitative analysis of NUP132 distribution and NPC organization?

For quantitative analysis of NUP132 and nuclear pore complex organization:

• Automated image analysis pipelines:

  • Measure average number of NPCs, nuclear surface area, and NPC density

  • Mid-G2 cells typically show approximately 120-130 NPCs per nucleus with density around 5-6 NPCs/μm²

  • Use nuclear envelope markers to normalize measurements

• Spatial distribution analysis:

  • Quantify clustering using nearest neighbor distance measurements

  • Analyze exclusion zones (e.g., around spindle pole bodies) where NPCs are absent

  • Compare wild-type distribution to mutant phenotypes

• Time-lapse imaging for dynamic studies:

  • Track NPC movement and reorganization during cell cycle progression

  • Quantify rates of assembly/disassembly in different genetic backgrounds

  • Correlate with functional readouts like mRNA export efficiency

Researchers should note that nuclear pore clustering occurs occasionally even in wild-type cells, suggesting functional relevance of this phenomenon beyond pathological states .

How does NUP132 interact with other components of the nuclear pore complex?

NUP132/NUP133 engages in multiple interactions within the nuclear pore complex network:

• Structural scaffold functions:

  • Forms part of the outer ring of the nuclear pore complex

  • Interacts with both FG-repeat containing nucleoporins and structural components

  • May extend into phase-separated regions of the NPC

• Functional interaction partners:

  • Co-immunoprecipitation studies reveal interactions with other nucleoporins including NUP98 and components of the mRNA export machinery

  • Synthetic lethal genetic interactions with other nucleoporins like NUP49 highlight functional relationships

• Role in NPC assembly pathway:

  • NUP132/NUP133 orthologs are required for proper NPC assembly

  • Clusters observed in mutants may represent defective assembly intermediates

  • Distinct domains of the protein contribute differently to NPC structure versus function

This complex interaction network positions NUP132/NUP133 as a critical component bridging structural and functional aspects of the nuclear pore complex.

What specific domains of NUP132 are recognized by different antibodies, and how does this affect experimental outcomes?

The domain-specific recognition of NUP132/NUP133 by antibodies has significant experimental implications:

• Functional domain accessibility:

  • N-terminal and C-terminal regions of nucleoporins often have differential accessibility to antibodies

  • For NUP132/NUP133, the amino-terminal domain is specifically involved in mRNA export function

  • Commercial antibodies typically target specific peptide regions (e.g., aa 650-700 for some human NUP133 antibodies)

• Experimental design considerations:

  • When designing studies, researchers should consider which functional domain needs to be detected

  • Antibodies recognizing different epitopes may yield contradictory results in different applications

  • For comprehensive analysis, use multiple antibodies targeting different domains

• Application-specific recommendations:

  • For studying mRNA export functions, prioritize antibodies targeting N-terminal domains

  • For structural studies, C-terminal epitopes may be more consistently accessible

  • Consider complementary approaches like tagged transgenes when studying multifunctional domains

Understanding domain-specific recognition is crucial when interpreting contradictory results between different antibody-based studies of the same protein.

How can NUP132 antibodies be used to investigate nuclear pore complex assembly and disassembly dynamics?

NUP132 antibodies offer valuable tools for investigating NPC dynamics:

• Cell cycle-dependent studies:

  • Synchronize cells at different cell cycle stages

  • Quantify NUP132 distribution and NPC density changes

  • Compare with other nucleoporins to establish assembly/disassembly sequence

• Pulse-chase approaches:

  • Combine with photoactivatable or photoconvertible fusion proteins

  • Track newly synthesized versus existing nucleoporin populations

  • Measure incorporation rates into intact NPCs versus clusters

• Stress response investigation:

  • Monitor NPC reorganization under various cellular stresses

  • Quantify changes in NUP132 localization during heat shock (particularly relevant given temperature-sensitive phenotypes)

  • Correlate structural changes with functional outcomes (mRNA export efficiency)

• Clustered NPC analysis:

  • Use NUP132 antibodies to characterize composition of clustered NPCs

  • Determine if clusters represent assembly intermediates, disassembly products, or aggregates of defective NPCs

  • Compare protein composition between normally distributed and clustered NPCs

This approach is particularly powerful when combined with genetic manipulations that affect NPC assembly pathways.

What controls are essential when using NUP132 antibodies for specific applications?

Essential controls for NUP132 antibody applications include:

• For immunofluorescence studies:

  • Negative controls: Wild-type cells without antibody and antibody on NUP132 knockout/knockdown cells

  • Positive controls: Known NPC markers (e.g., using mAb414 which recognizes multiple FG-nucleoporins)

  • Specificity controls: Peptide competition assays or siRNA-mediated depletion

  • Cross-reactivity assessment: Testing antibody against related nucleoporins

• For co-immunoprecipitation studies:

  • IgG control: Non-specific immunoprecipitation with matched isotype antibody

  • Input sample: Verification of target protein presence before precipitation

  • Reciprocal co-IP: Confirm interaction by precipitating with antibodies against binding partners

  • Stringency tests: IP under different salt/detergent conditions to confirm specificity

• For functional studies:

  • Rescue experiments: Complementation with wild-type protein after knockdown/knockout

  • Domain-specific mutants: Testing specific protein regions for functional requirements

  • Correlation with known phenotypes: mRNA export defects and NPC clustering

Proper controls are especially important given the complex architecture of the nuclear pore complex and potential antibody accessibility issues .

How can researchers overcome epitope masking or inaccessibility when detecting NUP132 in nuclear pore complexes?

Overcoming epitope masking or inaccessibility requires specialized approaches:

• Alternative detection strategies:

  • TurboID proximity labeling with streptavidin detection has been shown to access regions impenetrable to antibodies

  • This approach provides comparable resolution to antibody-based methods while avoiding accessibility problems

• Epitope tag positioning optimization:

  • Test both N-terminal and C-terminal tagging of NUP132/NUP133

  • Research shows dramatic differences in antibody accessibility depending on tag position

  • For example, some nucleoporins are accessible when tagged at one terminus but completely inaccessible when tagged at the other

• Enhanced extraction protocols:

  • More aggressive extraction methods can sometimes expose hidden epitopes

  • Caution: These may disrupt native protein interactions and localization

  • Validate with orthogonal methods to confirm findings

• Phase separation considerations:

  • Nucleoporins often reside in phase-separated regions resistant to antibody penetration

  • Modifying buffer conditions may temporarily disrupt phase separation to improve accessibility

  • Consider small molecules that disrupt phase separation while preserving protein localization

This combined approach maximizes the chances of successful detection while maintaining experimental integrity.

How might advanced imaging techniques enhance our understanding of NUP132 dynamics in living cells?

Emerging imaging approaches offer new opportunities for NUP132 research:

• Super-resolution microscopy applications:

  • STORM/PALM imaging can resolve individual nuclear pore complexes below the diffraction limit

  • This allows precise mapping of NUP132 position within the NPC architecture

  • Quantitative analysis of spatial relationships between different nucleoporins becomes possible

• Live-cell imaging strategies:

  • CRISPR-mediated endogenous tagging of NUP132 with fluorescent proteins

  • Photoactivatable or photoconvertible tags for pulse-chase experiments

  • Single-particle tracking to measure mobility and exchange rates between different NPC populations

• Correlative light and electron microscopy (CLEM):

  • Combine fluorescence imaging of NUP132 with ultrastructural analysis

  • This approach bridges the resolution gap between light microscopy and electron microscopy

  • Particularly valuable for understanding NPC clustering phenomena

• Lattice light-sheet microscopy:

  • Reduced phototoxicity allows extended imaging of NPC dynamics

  • Higher spatiotemporal resolution captures rapid reorganization events

  • Valuable for tracking NPC movements during cell division or stress responses

These advanced techniques will help resolve outstanding questions about NUP132's role in NPC assembly, organization, and function.

What experimental approaches can determine if NUP132 clusters represent assembly sites, disassembly products, or aggregation of defective NPCs?

To determine the nature of NUP132 clusters, researchers can implement these experimental strategies:

• Temporal analysis of cluster formation:

  • Time-lapse imaging of fluorescently tagged NUP132 and other nucleoporins

  • Track directional movement: Do individual NPCs move toward clusters or do clusters form in situ?

  • Measure protein exchange rates between clustered and non-clustered populations using FRAP (Fluorescence Recovery After Photobleaching)

• Compositional analysis of clusters:

  • Multi-color imaging to determine the presence/absence of different NPC components

  • Compare protein ratios between normal NPCs and clusters

  • Incomplete composition would suggest assembly/disassembly intermediates

• Functional studies:

  • Assess if clustered NPCs remain transport-competent using cargo import/export assays

  • Determine if mRNA export defects correlate with degree of clustering

  • Test if NPCs in clusters contain functional FG-repeat barriers

• Genetic interaction mapping:

  • Combine NUP132 mutations with other mutations affecting NPC assembly or disassembly

  • Assess synthetic phenotypes to place NUP132 in specific pathways

  • Compare with other factors known to affect NPC clustering, such as lipid-synthesis regulator Nem1

These approaches should help distinguish between the competing hypotheses about the nature of these intriguing structures.